DEXCOM, INC. Gain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31)
DEXCOM, INC. (DXCM) reported Gain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31) of $34.90 million for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-06.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnSaleOfSecuritiesNet · last filed 2018-11-06
- DEXCOM, INC. gain (loss) on sale of securities, net (deprecated 2018-01-31) for the quarter ending 2018-09-30 was $34.90M.
- DEXCOM, INC. gain (loss) on sale of securities, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $0.00.
| Period end | Gain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31) 3 month | Gain (Loss) on Sale of Securities, Net (Deprecated 2018-01-31) 9 month |
|---|---|---|
| 2018-09-30 | $34.90M 10-Q · filed 2018-11-06 | $85.00M 10-Q · filed 2018-11-06 |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-06 | $0.00 10-Q · filed 2018-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |